Economic Evaluation of Human Papillomavirus Vaccination in Developed Countries

2009 ◽  
Vol 12 (5-6) ◽  
pp. 343-351 ◽  
Author(s):  
Marc Brisson ◽  
Nicolas van de Velde ◽  
Marie-Claude Boily
Keyword(s):  
Human Papillomavirus ◽  
Economic Evaluation ◽  
Developed Countries ◽  
Human Papillomavirus Vaccination

A brief history of economic evaluation for human papillomavirus vaccination policy

Sexual Health ◽  
2010 ◽  
Vol 7 (3) ◽  
pp. 352 ◽  
Author(s):  
Philippe Beutels ◽  
Mark Jit
Keyword(s):  
Human Papillomavirus ◽  
Economic Evaluation ◽  
Policy Making ◽  
Cervical Screening ◽  
Hpv Vaccination ◽  
Health Economic Evaluation ◽  
Developed Countries ◽  
Economic Evaluations ◽  
Human Papillomavirus Vaccination ◽  
Screening Programs

Background: This commentary discusses key issues for health economic evaluation and modelling, applied to human papillomavirus (HPV) vaccine programs. Methods: We outline some of the specific features of HPV disease and vaccination, and associated policy questions in light of a literature search for economic evaluations on HPV vaccination. Results: We observe that some policy questions could not be reliably addressed by many of the 43 published economic evaluations we found. Despite this, policy making on universal HPV vaccination followed shortly after vaccine licensure in many developed countries, so the role economic evaluation played in informing these decisions (pre-dating 2008) seems to have been fairly limited. For more recent decisions, however, economic evaluation is likely to have been used more widely and more intensively. Conclusions: We expect future cost-effectiveness analyses to be more instrumental in policy making regarding vaccines covering more HPV types, therapeutic HPV vaccines, and novel diagnostic tests for biomarkers of HPV infection and disease integrated with cervical screening programs.

Human Papillomavirus Vaccination in the Prevention of Cervical Neoplasia

2009 ◽  
Vol 19 (9) ◽  
pp. 1610-1613 ◽  
Author(s):  
Katharine Astbury ◽  
Michael J. Turner
Keyword(s):  
Cervical Cancer ◽  
Human Papillomavirus ◽  
Disease Incidence ◽  
Developed Countries ◽  
Cervical Neoplasia ◽  
Human Papillomavirus Vaccination ◽  
Vaccination Programs ◽  
Screening Programs ◽  
Hpv 18

Cervical cancer remains a major cause of morbidity and mortality for women worldwide. Although the introduction of comprehensive screening programs has reduced the disease incidence in developed countries, it remains a major problem in the developing world. The recent licensing of 2 vaccines against human papillomavirus (HPV) type 16 and HPV-18, the viruses responsible for 70% of cervical cancer cases, offers the hope of disease prevention. In this article, we review the role of HPV in the etiology of cervical cancer and the evidence to support the introduction of vaccination programs in young women and discus the potential obstacles to widespread vaccination. In addition, we discuss the issues that remain to be elucidated, including the potential need for booster doses of the vaccine and the role of concomitant vaccination in men.

Economic evaluation of human papillomavirus vaccination in the Global South: a systematic review

2020 ◽  
Vol 65 (7) ◽  
pp. 1097-1111
Author(s):  
Saba Abidi ◽  
Satyanarayana Labani ◽  
Aastha Singh ◽  
Smita Asthana ◽  
Puneeta Ajmera
Keyword(s):  
Systematic Review ◽  
Human Papillomavirus ◽  
Economic Evaluation ◽  
Global South ◽  
Human Papillomavirus Vaccination

The ethics of implementing human papillomavirus vaccination in developed countries

2010 ◽  
Vol 14 (1) ◽  
pp. 19-27 ◽  
Author(s):  
Erik Malmqvist ◽  
Gert Helgesson ◽  
Johannes Lehtinen ◽  
Kari Natunen ◽  
Matti Lehtinen
Keyword(s):  
Human Papillomavirus ◽  
Developed Countries ◽  
Human Papillomavirus Vaccination

scholarly journals Economic evaluation of human papillomavirus vaccination in the United Kingdom

BMJ ◽  
2008 ◽  
Vol 337 (jul17 2) ◽  
pp. a769-a769 ◽  
Author(s):  
M. Jit ◽  
Y. H. Choi ◽  
W J. Edmunds
Keyword(s):  
United Kingdom ◽  
Human Papillomavirus ◽  
Economic Evaluation ◽  
Human Papillomavirus Vaccination ◽  
The United Kingdom
Sign in / Sign up

Export Citation Format

Share Document